Biopharmaceutical Innovation and Access: Incenting Appropriate Utilization

NEHI’s policy agenda is embedded in the projects it pursues. These are driven primarily by its members. But NEHI’s access to policy makers, patient advocacy groups, and other key stakeholders help it shape projects as well. The projects identified seek to strike a balance between work that address well defined, immediate issues, and those that, because of their complexity, require extended dissection and analysis, and the iteration of solutions over time.

Filter Initiatives By Theme:

Initiatives

Showing : 21–30 of 30

Publication Date: September 1, 2010

From Evidence to Practice: Making CER Findings Work for Providers and Patients

This issue brief identifies a number of major factors found by NEHI research that could influence the creation of a coherent and effective CER dissemination strategy.
View More
Publication Date: August 12, 2009

Thinking Outside the Pillbox: A System-wide Approach to Improving Patient Medication Adherence for Chronic Disease

This issue brief addresses the root causes of poor patient medication adherence - a significant contributor to overall health care waste - and offers promising solutions to improve adherence, particularly among chronic disease patients.
View More
Publication Date: April 20, 2009

Balancing Act: Comparative Effectiveness Research and Innovation in U.S. Health Care

This white paper, representing the views of a broad range of health care stakeholders, provides a first-of-its-kind framework for designing and implementing a federal CER program that will sustain the unique dynamics of innovation in health care.
View More
Publication Date: July 21, 2008

Comparative Effectiveness Research

A summary of NEHI's work in comparative effectiveness research.
View More
Publication Date: February 25, 2008

Improving Physician Adherence to Clinical Practice Guidelines

To address the variance between agreed-upon standards of care and actual care provided by strengthening physician guidelines, we must overcome key barriers to adherence.
View More
Publication Date: January 1, 2006

Insulin Analogs: Innovation in Biotechnology

Insulin analog drugs, used in combination therapy, are valuable and cost-effective for type 1 diabetes patients.
View More
Publication Date: March 1, 2005

Continuous Glucose Monitoring: Innovation in the Management of Diabetes

CGM devices have potential to be highly valuable and cost-effective tools in managing diabetes.
View More
Publication Date: March 1, 2004

Targeting Cancer: Innovation in the Treatment of Chronic Myelogenous Leukemia

The adoption of Gleevec, a pioneering drug in the treatment of CML, highlights challenges and opportunities in bringing drugs treating rare diseases to market.

View More
Publication Date: January 1, 2004

On the Critical List: Health Care Job Vitality in New England

Given New England's historic stronghold in key segments of the health care industry and its importance to the well-being of the region's economy and citizens, it is critical that measures are taken to reinvigorate growth and to ensure New England's strength from bench to bedside.
View More
Publication Date: February 1, 2003

The Economic Contributions of the Health Care Industry to the New England Region

New England must take steps to maintain its national leadership in health care employment, reverse the decline in employment growth and make the region more attractive to health care employers.
View More